Comparison of outcomes in patients with methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia who are treated with β-lactam vs vancomycin empiric therapy: a retrospective cohort study

Overview of attention for article published in BMC Infectious Diseases, May 2016

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (73rd percentile)
High Attention Score compared to outputs of the same age and source (81st percentile)

So far, Altmetric has seen 9 X posts from 9 X users, with an upper bound of 11,886 followers.

MS-SABの経験的治療でVCMを使用するのはOKだが標的治療ではCEZに劣る 3日を超えるVCMのみの投与は避けた方がいい https://t.co/rs24G2Gj0W #タブ整理

カナダの単施設後ろ向き観察研究。MSSA bacteremiaに対する経験的VCMはβLと比較し28日・90日死亡率は不変。ただしβL郡でIEが多い。VCM群でβLへのswitchは67.8時間以内に行われた。 https://t.co/5klTiAPs6K

https://t.co/TKTUGBZGpr cefazolinだけじゃないけども昨日に引き続き抗菌薬。回帰。 https://t.co/K5QRK7g88t

RT @AntibioticLeeds: Comparison of outcomes in patients MSSA bacteraemia: vancomycin vs beta-lactam. @ESGAP_ABS #ukcpapinjc https://t.co/TE…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 5 additional X posts.